Literature DB >> 2182737

Serum immunoreactive erythropoietin in health and disease.

J L Spivak1.   

Abstract

The currently available radioimmunoassay for erythropoietin (Epo) using recombinant reagents is an accurate, reproducible, sensitive and specific assay which can be used to identify whether lack of Epo is contributing to anemia and, by extension, whether therapy with recombinant Epo might be appropriate. Elevation of the serum Epo level with anemia suggests that a marrow abnormality is the cause of the anemia, while a "high" Epo level in a non-anemic or plethoric patient suggests the presence of hypoxia or autonomous Epo production. Liver disease can elevate the serum Epo level, while modest degrees of anemia do not affect it appreciably. The lowest Epo levels occur in polycythemia vera, but in a particular patient this finding is not completely diagnostic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182737     DOI: 10.1002/stem.5530080720

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  3 in total

1.  Human erythropoietin response to hypocapnic hypoxia, normocapnic hypoxia, and hypocapnic normoxia.

Authors:  T Klausen; H Christensen; J M Hansen; O J Nielsen; N Fogh-Andersen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

2.  Diurnal variations of serum erythropoietin at sea level and altitude.

Authors:  T Klausen; T D Poulsen; N Fogh-Andersen; J P Richalet; O J Nielsen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

3.  Hypoproduction of erythropoietin contributes to anemia in chronic cadmium intoxication: clinical study on Itai-itai disease in Japan.

Authors:  H Horiguchi; H Teranishi; K Niiya; K Aoshima; T Katoh; N Sakuragawa; M Kasuya
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.